Investment
Features
FeesSafety
Academy
More
Pluang+

Irvine Spectrum Center unveils new 132-foot Spectrum SunWheel with enhanced features and views

Others
17 Sep 2026
PRNewsWire
View Source
Neutral
Irvine Spectrum Center unveils new 132-foot Spectrum SunWheel with enhanced features and views

Irvine Spectrum Center in Southern California has opened the new Spectrum SunWheel, a 132-foot tall observation wheel that replaces the previous Giant Wheel. Manufactured by Italy's Fabbri Group, the SunWheel offers 27 gondolas with improved audio, LED lighting, and faster ride operations, providing visitors stunning views and a modernized experience. The grand opening event includes live music and free rides for the first 300 guests. This attraction aims to enhance the center's appeal as a premier shopping and entertainment destination.

The Spectrum SunWheel debut at Irvine Spectrum Center offers context for consumer cyclical stocks. For readers following this sector, here is Pluang's market snapshot as of Sep 17, 2026 21:16 WIB: Out of 105 priced US stocks, 71 rose and 33 fell. Notable movers include LCID at USD 4.48 with a +10.89% change and 100% buy order activity, QS at USD 5.24 with a +4.70% change and 97% sell order activity, and RIVN at USD 15.94 with a +4.66% change and 100% buy order activity.

More News

New version of Freenome's blood test shows improved detection of advanced precancerous colorectal lesions

New version of Freenome's blood test shows improved detection of advanced precancerous colorectal lesions

Freenome announced improved clinical validation results for its updated SimpleScreen™ CRC blood test, showing an 18.2% sensitivity for advanced precancerous lesions (APLs), up from 13.7% in the original test. Sensitivity for high-grade dysplasia APLs...

Market News
Bullish
40 minutes ago
Encaleret boosts bone turnover and improves symptoms in ADH1 patients, with FDA Priority Review underway.

Encaleret boosts bone turnover and improves symptoms in ADH1 patients, with FDA Priority Review underway.

BridgeBio Pharma announced that encaleret, a treatment for autosomal dominant hypocalcemia type 1 (ADH1), increased bone turnover and improved patient-reported symptoms in the Phase 3 CALIBRATE trial. 100% of patients on encaleret reported symptom im...

Company Fundamentals
Bullish
1 hour ago
Bitcoin price nears $84K but lacks momentum for a strong breakout, facing resistance at $83,900-$84,200.

Bitcoin price nears $84K but lacks momentum for a strong breakout, facing resistance at $83,900-$84,200.

Bitcoin's price is holding near $83,770 after recovering from a low of $80,308, but it struggles to break above the $83,900 to $84,200 resistance zone. Short-term moving averages show mixed signals, while longer-term averages remain positive, indicat...

Technical Signals
Neutral
4 hours ago
Remittix sets final RTX presale price at $0.46 ahead of November launch amid XRP and Zcash market buzz

Remittix sets final RTX presale price at $0.46 ahead of November launch amid XRP and Zcash market buzz

Remittix announced its final presale price for the RTX token at $0.46, set as the minimum exchange launch price for its market debut on November 24, 2026. Currently, RTX is available at $0.23 during the ongoing presale stage, with the project nearing...

Market News
Bullish
4 hours ago
Pasqal Holding investigated for securities violations after misleading investors on defense program role

Pasqal Holding investigated for securities violations after misleading investors on defense program role

Block & Leviton is investigating Pasqal Holding for potentially misleading investors about its involvement in a French defense quantum-computing program. Pasqal announced ending its participation after the first phase, describing it as an "evolution"...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App